TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18505372

Group type: EXPERIMENTAL
Intervention: 800 mg oral clodronate (Bonefos) daily over 3 years
Number of subjects: 5157

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 5157
Study: 17179457

Group type: COMPARATOR
Intervention: Reasoning training
Number of subjects: 2832

Group type: COMPARATOR
Intervention: Speed of processing training
Number of subjects: 2832

Group type: COMPARATOR
Intervention: Memory training
Number of subjects: 2832

Group type: COMPARATOR
Intervention: Booster training for speed of processing
Number of subjects: 2832

Group type: COMPARATOR
Intervention: Booster training for reasoning
Number of subjects: 2832

Group type: COMPARATOR
Intervention: Cognitive training overall
Number of subjects: 2832
Study: 12628950

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Enalapril (in patients with impaired FPG)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo (in patients with impaired FPG)
Number of subjects: 291
Study: 10817062

Group type: EXPERIMENTAL
Intervention: Persistent HPV16 infection
Number of subjects: 74447

Group type: EXPERIMENTAL
Intervention: Cervical intraepithelial neoplasia grade III and cervical cancer (CIN III+)
Number of subjects: 74447
Study: 8993761

Group type: EXPERIMENTAL
Intervention: Single dose of anti-herpes dialysate (AH-DLE)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Two doses of anti-herpes dialysate (AH-DLE)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Three doses of anti-herpes dialysate (AH-DLE)
Number of subjects: 37
Study: 1476047

Group type: EXPERIMENTAL
Intervention: Egg exclusion diet
Number of subjects: 0
Study: 6379630

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray (100 micrograms into each nostril twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate pressurized nasal spray (100 micrograms into each nostril twice daily)
Number of subjects: 40
Study: 30764814

Group type: EXPERIMENTAL
Intervention: Online teaching on suicide prevention via brief online videos plus two standardized patient (SP) interactions (face-to-face and telehealth)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online teaching on suicide prevention via brief online videos
Number of subjects: 0
Study: 30396620

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise for 8 weeks
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no Tai Chi)
Number of subjects: 132
Study: 26938814

Group type: EXPERIMENTAL
Intervention: Chlorthalidone/amiloride (12.5/2.5 mg)
Number of subjects: 655

Group type: COMPARATOR
Intervention: Losartan (50 mg)
Number of subjects: 655
Study: 25442824

Group type: EXPERIMENTAL
Intervention: Artificial shrinkage of blastocoele using laser pulse
Number of subjects: 185
Study: 21902621

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) 75 mg qd then 25 mg qd
Number of subjects: 368

Group type: COMPARATOR
Intervention: Efavirenz (EFV) 600 mg qd
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 368
Study: 20935517

Group type: EXPERIMENTAL
Intervention: Monovalent A (H1N1) pandemic vaccine (Panenza®)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trivalent split inactivated vaccine (Vaxigrip®)
Number of subjects: 0
Study: 18595959

Group type: EXPERIMENTAL
Intervention: Intranasal budesonide (32 microg per nostril at bedtime)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 16208072

Group type: EXPERIMENTAL
Intervention: Drug misuse and abuse prevention program (1 hour, once a week for 5 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 49
Study: 12587769

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 100

Group type: COMPARATOR
Intervention: Panadeine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Etodolac
Number of subjects: 100

Group type: COMPARATOR
Intervention: All three drugs
Number of subjects: 100
Study: 10999082

Group type: EXPERIMENTAL
Intervention: Sequential Drug Monotherapy (SDM)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Step Care Therapy (SCT)
Number of subjects: 70
Study: 8527293

Group type: EXPERIMENTAL
Intervention: Lactose (various doses)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (empty dose)
Number of subjects: 20
Study: 2255839

Group type: EXPERIMENTAL
Intervention: Ivermectin 50 mcg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ivermectin 100 mcg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ivermectin 150 mcg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ivermectin 200 mcg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (non-treated carriers)
Number of subjects: 40
Study: 7237448

Group type: EXPERIMENTAL
Intervention: ethinyl estradiol (EE2)
Number of subjects: 63

Group type: COMPARATOR
Intervention: tamoxifen
Number of subjects: 63
Study: 31893396

Group type: EXPERIMENTAL
Intervention: Thigh-cuff-release technique (220 mmHg for 3 min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Progressive hypoxia (FiO2 at 21%, 18%, 15%, and 12%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thigh-cuff-release technique (220 mmHg for 3 min) during progressive hypoxia
Number of subjects: 10
Study: 30760256

Group type: EXPERIMENTAL
Intervention: Mulligan's Mobilisation With Movement (MWM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (detuned laser)
Number of subjects: 0
Study: 28098838

Group type: EXPERIMENTAL
Intervention: Silymarin (oral doses)
Number of subjects: 33
Study: 26485380

Group type: EXPERIMENTAL
Intervention: Active occlusal interference (AI)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Dummy interference (DI)
Number of subjects: 7
Study: 23504490

Group type: EXPERIMENTAL
Intervention: Fanning technique
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard technique
Number of subjects: 54
Study: 21873912

Group type: EXPERIMENTAL
Intervention: DigniCare Stool Management System (device A)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flexi-Seal Fecal Management System (device B)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ActiFlo Indwelling Bowel Catheter System (device C)
Number of subjects: 10
Study: 19479385

Group type: EXPERIMENTAL
Intervention: Satranidazole mucoadhesive gel (SC30 formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marketed metronidazole gel (Metrogyl gel)
Number of subjects: 0
Study: 17589294

Group type: EXPERIMENTAL
Intervention: Modified HLA‐A2‐binding gp100(209‐2M) peptide vaccination
Number of subjects: 0
Study: 15519186

Group type: EXPERIMENTAL
Intervention: HAES‐steril 6% (HES 200/0.5)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Voluven 6% (HES 130/0.4)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (Ringer's lactate group)
Number of subjects: 20
Study: 11527062

Group type: EXPERIMENTAL
Intervention: Bee venom acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional needle acupuncture
Number of subjects: 0
Study: 9753216

Group type: EXPERIMENTAL
Intervention: Systemic hypothermia
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Neuropsychological testing
Number of subjects: 131
Study: 7836706

Group type: EXPERIMENTAL
Intervention: Bleeding episodes
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cessation of bleeding
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Rebleeding episodes
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Previous rebleedings and time since first bleeding
Number of subjects: 94
Study: 3221374

Group type: EXPERIMENTAL
Intervention: Nitrendipine 10-20 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxprenolol 160 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine 75-300 micrograms per day
Number of subjects: 0
Study: 30231990

Group type: EXPERIMENTAL
Intervention: Low-dose radiation therapy (LDRT) - 6 × 1 Gy in 2 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham treatment - 6 × 0 Gy in 2 weeks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pain and functioning measured by AUSCAN
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Quality of life measured by SF36
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Inflammatory outcomes (erythrocyte sedimentation rate, C-reactive protein serum levels, effusion, synovial thickening, power Doppler signal on ultrasound)
Number of subjects: 56
Study: 26418670

Group type: EXPERIMENTAL
Intervention: Interferon and ribavirin treatment for 12 weeks (Finnish patients)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Interferon and ribavirin treatment for 12-16 weeks (Swedish patients)
Number of subjects: 372
Study: 25338961

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%) with epinephrine (1:200,000) as supplemental anesthesia at the end of surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (placebo) as supplemental anesthesia at the end of surgery
Number of subjects: 40
Study: 22552838

Group type: EXPERIMENTAL
Intervention: Healthy Eating and Exercise Lifestyle Program (HEELP)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 148
Study: 20534751

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (4 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (20 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 19034033

Group type: EXPERIMENTAL
Intervention: Ambroxol administered orally for a week before and after surgery (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (control group, n = 25)
Number of subjects: 50
Study: 17803434

Group type: EXPERIMENTAL
Intervention: Tafluprost 0.005%
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Tafluprost 0.0025%
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 15328547

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 32
Study: 10867155

Group type: EXPERIMENTAL
Intervention: AZT+3TC
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: AZT+ddI
Number of subjects: 19
Study: 9101195

Group type: EXPERIMENTAL
Intervention: Second trabeculectomy with mitomycin-C (MMC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Second trabeculectomy without mitomycin-C (MMC)
Number of subjects: 46
Study: 8403177

Group type: EXPERIMENTAL
Intervention: 0.2 mg sublingual triazolam
Number of subjects: 100

Group type: COMPARATOR
Intervention: 10 mg oral diazepam
Number of subjects: 100
Study: 3709641

Group type: EXPERIMENTAL
Intervention: 25 mg of PY 108‐068
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 50 mg of PY 108‐068
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29055031

Group type: EXPERIMENTAL
Intervention: Gender-neutral vaccination with AS04-adjuvanted HPV16/18 vaccine (Arm A)
Number of subjects: 39420

Group type: EXPERIMENTAL
Intervention: HPV vaccination of girls and hepatitis B-virus (HBV) vaccination of boys (Arm B)
Number of subjects: 39420

Group type: COMPARATOR
Intervention: Gender-neutral HBV vaccination (Arm C)
Number of subjects: 39420
Study: 27536947

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rituximab and Placebo
Number of subjects: 70
Study: 25468084

Group type: EXPERIMENTAL
Intervention: Leaflet reconstruction techniques including leaflet plication, nodular unfolding, double pericardial patching, complete pericardial leaflet replacement, leaflet extension, Gore‐Tex reinforcement
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Gore‐Tex reinforcement and leaflet extension
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Single pericardial leaflet replacements and double pericardial reconstructions
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Interval valve replacement
Number of subjects: 65
Study: 21798721

Group type: EXPERIMENTAL
Intervention: Ziprasidone (80-160 mg/d) plus mood stabilizer (lithium or valproate)
Number of subjects: 584

Group type: COMPARATOR
Intervention: Placebo plus mood stabilizer (lithium or valproate)
Number of subjects: 584
Study: 20437789

Group type: EXPERIMENTAL
Intervention: Minimized extracorporeal circulation (MECC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (CCPB)
Number of subjects: 40
Study: 18682411

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O)‐based anaesthesia
Number of subjects: 2050

Group type: COMPARATOR
Intervention: Nitrous oxide (N2O)‐free anaesthesia
Number of subjects: 2050
Study: 15996411

Group type: EXPERIMENTAL
Intervention: Polidocanol (POL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sodium tetradecyl sulfate (STS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Polidocanol (POL) and Sodium tetradecyl sulfate (STS)
Number of subjects: 20
Study: 12858461

Group type: EXPERIMENTAL
Intervention: NMES plus education
Number of subjects: 34

Group type: COMPARATOR
Intervention: Education only (EDU)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 10551071

Group type: EXPERIMENTAL
Intervention: Demineralized freeze-dried bone allografts (DFDBA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Deproteinized natural bovine bone mineral xenograft (DBBMX)
Number of subjects: 24
Study: 8677906

Group type: EXPERIMENTAL
Intervention: Ifosfamide 1.5 g/m2 and mesna at 30% of the ifosfamide dose, administered i.v. daily for 5 days every 21 days.
Number of subjects: 38
Study: 1815962

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verapamil (after oral pretreatment)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 8
Study: 6824300

Group type: EXPERIMENTAL
Intervention: 0.5% plain bupivacaine (3.5 ml)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 0.5% plain bupivacaine (3 ml)
Number of subjects: 340
Study: 31271569

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine A 0.05% (twice a day for 10 days before and 10 days after surgery)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (31 patients who did not receive cyclosporine treatment)
Number of subjects: 76
Study: 29464877

Group type: EXPERIMENTAL
Intervention: Patient navigation program
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1200
Study: 27155962

Group type: EXPERIMENTAL
Intervention: Compression Socks with Textured Insoles (CSTI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Compression Socks with Smooth Insoles (CSSI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Smooth Socks with Textured Insoles (SSTI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Smooth Socks with Smooth Insoles (SSSI)
Number of subjects: 12
Study: 25410066

Group type: EXPERIMENTAL
Intervention: Horsetail mixture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified what the control was)
Number of subjects: 60
Study: 21982875

Group type: EXPERIMENTAL
Intervention: Moderate to vigorous aerobic exercise for 1 year
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual inactivity
Number of subjects: 100
Study: 20848900

Group type: EXPERIMENTAL
Intervention: Tranquilization Needling (TN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Eight Confluence Acupoints (ECA)
Number of subjects: 60
Study: 17641562

Group type: EXPERIMENTAL
Intervention: Japanese acupuncture
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine acupuncture
Number of subjects: 7

Group type: COMPARATOR
Intervention: Both acupuncture styles
Number of subjects: 7

Group type: COMPARATOR
Intervention: Neither group
Number of subjects: 7
Study: 15731510

Group type: EXPERIMENTAL
Intervention: Directed learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-directed learning
Number of subjects: 0
Study: 12205259

Group type: EXPERIMENTAL
Intervention: Rectal acetaminophen 15 mg/kg (Group A)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Rectal acetaminophen 30 mg/kg (Group B)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Oral acetaminophen 15 mg/kg (Group C)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Visual analog scores for satisfaction of parents
Number of subjects: 70
Study: 9809555

Group type: EXPERIMENTAL
Intervention: T-20 (100 mg twice daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: T-20 (various doses)
Number of subjects: 16
Study: 7665721

Group type: EXPERIMENTAL
Intervention: Lornoxicam 4 mg
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Lornoxicam 16 mg
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Lornoxicam 32 mg
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 2819565

Group type: EXPERIMENTAL
Intervention: Water added to incubators
Number of subjects: 180

Group type: COMPARATOR
Intervention: No water added to incubators (control)
Number of subjects: 180
Study: 173048

Group type: EXPERIMENTAL
Intervention: Eladent cleaner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kukident cleaner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Steradent cleaner
Number of subjects: 0
Study: 29877778

Group type: EXPERIMENTAL
Intervention: Patient Self-Management (PSM) group
Number of subjects: 87

Group type: COMPARATOR
Intervention: Patient Self-Testing (PST) group
Number of subjects: 87
Study: 28587629

Group type: EXPERIMENTAL
Intervention: USMART program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 25369608

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (mean dose 7-9 g)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 23100042

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 5

Group type: COMPARATOR
Intervention: PCV
Number of subjects: 5
Study: 21790518

Group type: EXPERIMENTAL
Intervention: Pudendal nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dorsal penile nerve block
Number of subjects: 60
Study: 19432498

Group type: EXPERIMENTAL
Intervention: olmesartan/amlodipine 40/5 mg
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: olmesartan/amlodipine 40/10 mg
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: olmesartan/amlodipine/HCTZ 40/10/12.5 mg
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: olmesartan/amlodipine (+/− HCTZ)
Number of subjects: 692
Study: 17061974

Group type: EXPERIMENTAL
Intervention: Information about the early fertile time from the fertility monitor (first rise in E3G until LH surge)
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Information about the late fertile time from the fertility monitor (onset of LH surge and following 2 days)
Number of subjects: 1453

Group type: COMPARATOR
Intervention: No information from the fertility monitor (control group)
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Late Fertile Time group
Number of subjects: 1453
Study: 10578975

Group type: EXPERIMENTAL
Intervention: PCR-based assay to detect HSV-1 and HSV-2 in ThinPrep fixative
Number of subjects: 5
Study: 8767242

Group type: EXPERIMENTAL
Intervention: Halothane (HAL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Enflurane (ENF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Isoflurane (ISO)
Number of subjects: 36
Study: 1662585

Group type: EXPERIMENTAL
Intervention: low-alcohol beer
Number of subjects: 72

Group type: COMPARATOR
Intervention: usual drinking habits
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: plasma fatty acid concentrations
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: logistic regression indices combining plasma apolipoprotein A‐II and linoleic acid concentrations
Number of subjects: 72
Study: 7060825

Group type: EXPERIMENTAL
Intervention: UDCA 12 mg/kg/day
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: UDCA 8 mg/kg/day
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: UDCA 4 mg/kg/day
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study: 30883056

Group type: EXPERIMENTAL
Intervention: Antibacterial envelope
Number of subjects: 6983

Group type: COMPARATOR
Intervention: Standard-of-care strategies (Control)
Number of subjects: 6983
Study: 29419437

Group type: EXPERIMENTAL
Intervention: Rituximab plus bendamustine
Number of subjects: 357

Group type: COMPARATOR
Intervention: Rituximab plus chlorambucil
Number of subjects: 357
Study: 26718894

Group type: EXPERIMENTAL
Intervention: 10 minute Active Lesson Break
Number of subjects: 58

Group type: COMPARATOR
Intervention: 10 minute Passive Lesson Break (reading)
Number of subjects: 58
Study: 24603054

Group type: EXPERIMENTAL
Intervention: FemoSeal vascular closure device (VCD)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Manual compression (MC)
Number of subjects: 1001
Study: 22307572

Group type: EXPERIMENTAL
Intervention: Men in 2008 with lower serum free testosterone compared to men in 1995
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) in women in 2008
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Fracture incidence in postmenopausal women in 2008
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Vertebral crush fractures in women
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Serum cholesterol and triglycerides
Number of subjects: 2400
Study: 20973712

Group type: EXPERIMENTAL
Intervention: Aripiprazole (flexibly dosed 2-15 mg/day)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Aripiprazole (fixed dose 5, 10, or 15 mg/day)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo (flexibly dosed)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo (fixed dose)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Aripiprazole (both dosing regimens)
Number of subjects: 316
Study: 17052252

Group type: EXPERIMENTAL
Intervention: Doxazosin (standard tablet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS (controlled release formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doxazosin, Tamsulosin, Terazosin, Prazosin (α1-receptor antagonists)
Number of subjects: 0